ECT

ECT
Name	Electroconvulsive therapy
Synonyms	ECT
Specialty	Psychiatry, Neurology

ECT

Electroconvulsive therapy is a medical procedure that induces controlled seizures for therapeutic benefit in severe psychiatric and neurological conditions. It is administered in clinical settings by multidisciplinary teams including psychiatrists, anesthesiologists, and nurses from institutions such as Mayo Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital. Developed through historical advances linked to figures associated with Freud-era psychiatry and institutional practice reform movements exemplified by National Institute of Mental Health-funded programs, the treatment has been shaped by changing regulatory frameworks like those instituted by the United States Food and Drug Administration and national health services including National Health Service (England).

History

Early 20th-century explorations of convulsive therapies occurred alongside contemporaneous biomedical experiments at places like Charité – Universitätsmedizin Berlin and laboratories associated with University of Vienna. Pioneering clinical implementation in the 1930s was contemporaneous with work by clinicians in institutions comparable to West Riding Pauper Lunatic Asylum and influenced by ideas circulating in the era of Jakob von Uexküll-era physiology. Mid-century adoption accelerated in psychiatric hospitals such as St. Elizabeths Hospital and became prominent in accounts involving public figures treated at centers like Bellevue Hospital. Controversies paralleling debates over psychosurgery at institutions like Harvard Medical School and regulatory scrutiny by bodies like Royal College of Psychiatrists have shaped practice standards into the 21st century.

Medical Uses and Indications

ECT is indicated for severe, treatment-resistant major depressive disorder, acute suicidality, catatonia, and some forms of bipolar disorder; these indications are reflected in guidelines from organizations such as American Psychiatric Association, World Health Organization, and National Institute for Health and Care Excellence. It is also used in refractory psychotic states and certain neuropsychiatric manifestations seen in referrals from centers like Cleveland Clinic and Charité. In pregnancy, ECT has been considered by multidisciplinary teams at institutions such as University of California, San Francisco when pharmacotherapy poses teratogenic risks—decisions informed by case series originating from tertiary centers including Johns Hopkins Hospital. Off-label and experimental uses have been explored in specialized research at universities like Yale University and Columbia University.

Procedure and Techniques

ECT is performed under general anesthesia with short-acting agents administered by anesthesiologists from departments modeled after Mayo Clinic protocols, with muscle relaxation provided by agents like succinylcholine used in operating theaters akin to those at Massachusetts General Hospital. Electrode placement can be unilateral or bilateral; techniques were refined in training programs at institutions such as University College London and Stanford University School of Medicine. Stimulus dosing and waveform choices—brief pulse, ultrabrief pulse, sine wave—have been compared in clinical trials coordinated by research centers including National Institute of Mental Health and King's College London. Monitoring includes electroencephalography and cardiopulmonary surveillance similar to standards at Cleveland Clinic and Hospital das Clínicas da Universidade de São Paulo.

Mechanism of Action

The mechanistic basis invokes neurophysiological and neurochemical changes observed in studies from laboratories at institutions like Columbia University, University of California, San Diego, and Karolinska Institutet. Proposed processes include modulation of monoaminergic systems described in reviews linked to Harvard Medical School, alterations in regional cerebral blood flow documented in imaging studies at Massachusetts General Hospital, and neuroplastic effects involving neurotrophic factors studied at University of Pennsylvania. Network-level hypotheses draw on functional imaging datasets analyzed by groups at Washington University in St. Louis and computational models developed at California Institute of Technology.

Efficacy and Outcomes

Randomized and observational studies from centers including Oxford University, Johns Hopkins Hospital, and McMaster University report high response rates in severe depression, often exceeding outcomes from pharmacotherapy trials led by Vanderbilt University Medical Center and Duke University Medical Center. Meta-analyses conducted by consortia involving Cochrane Collaboration contributors and systematic reviewers at Imperial College London have characterized remission and relapse rates, while maintenance strategies—continuation ECT or neuromodulation alternatives developed at University of Toronto—are informed by comparative trials.

Adverse Effects and Safety

Common acute adverse effects reported in clinical series from institutions like Mayo Clinic include transient headache, nausea, and cardiovascular changes; cognitive adverse effects—anterograde and retrograde amnesia—have been profiled in neuropsychological studies from University College London, Karolinska Institutet, and McLean Hospital. Serious medical complications are rare in cohorts treated at tertiary centers such as Johns Hopkins Hospital and Cleveland Clinic, and perioperative risk management follows protocols influenced by guidelines from American Society of Anesthesiologists.

Ethics and Legal Considerations

Ethical debates around informed consent, capacity assessment, and mandated treatment involve jurisprudence and policy from courts and bodies such as Supreme Court of the United States, European Court of Human Rights, and legislative frameworks in jurisdictions represented by Parliament of the United Kingdom and United States Congress. Advocacy and patient-rights perspectives from organizations like Mental Health America and National Alliance on Mental Illness have influenced regulatory oversight exemplified by United States Food and Drug Administration actions and professional guidelines issued by American Psychiatric Association.

Category:Psychiatry